Hence, further research is warranted to explore the prognostic and diagnostic value of Neurotrophin-3 in MD, its role in pathogenesis, and the efficacy of Neurotrophin-3-targeted treatments, leveraging insights from previous studies on mood disorders and this MR study. The gene discussed is NTF3; the disease is Menkes disease.